Articles tagged with Immunotherapy
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A new study from UTMB reveals that a single dose of immunotherapy reverses memory problems in an animal model of Alzheimer's disease. The therapy targets toxic tau oligomers, which are also linked to amyloid beta levels.
Hay fever sufferers can benefit from state-of-the-science treatments like sublingual immunotherapy. The American Academy of Otolaryngology recommends this treatment for patients with specific allergies who don't respond to other treatments, with a completion period of up to five years. Other key recommendations include diagnosing and t...
Krishnaraj Rajalingam, a leading molecular cell biologist, has been awarded the Gutenberg Research College fellowship to establish a research team at Mainz University. His research focuses on understanding cellular signaling pathways to develop novel therapeutics for major human diseases like cancer.
Researchers at UC Davis found that immunotherapy regimens can be lethal to obese mice due to increased body fat, which affects the immune system's response. The study suggests a link between obesity and toxicity in cancer treatment outcomes.
Researchers found combining immunotherapy with radiotherapy helps the immune system target and destroy cancer cells resistant to initial treatment. This approach improved survival rates and protected mice against disease recurrence.
Researchers found that adding rapamycin to an immunotherapy approach strengthened the immune response against brain tumor cells, increasing the effect of new therapies. The study also showed increased memory cells, allowing the immune system to attack tumors more effectively.
A new vaccine candidate, GP2, has shown a 57% reduction in recurrence rates among high-risk breast cancer patients. The vaccine targets CD8+ cells and was combined with an immune stimulant to enhance its effectiveness.
Researchers at the University of Bristol have made a breakthrough in understanding how cells convert from attacking healthy tissue to protecting against disease. This discovery could lead to the development of a new treatment approach using antigen-specific immunotherapy, which may improve the lives of millions worldwide.
A new triple therapy combining two immunotherapies and targeted radiation has prolonged the survival of mice with glioblastoma brain cancer by up to 67 days. The treatment induces an immune response against tumors, creating long-term immunity.
Researchers found that treating a peanut allergy with oral immunotherapy changes the DNA of immune cells, which could serve as a basis for a simple blood test to monitor long-term effectiveness. The study involved 20 peanut-allergic children and adults who completed two years of immunotherapy.
Dr. Rodriguez's award-winning research identified a potential new therapeutic approach to make T cells resistant to tumor suppression, enhancing anti-tumor activity and overcoming immune suppression. His findings suggest Notch-1 may be an effective new approach for T cell-based immunotherapy.
Research suggests that pregnant women who receive allergy shots may reduce their child's risk of asthma, food allergies, and eczema. Allergy shots, also known as immunotherapy, can modify and prevent disease progression.
A study by Timothy Craig, MD, found that allergy shots decrease anxiety and depression in those allergic to wasp, bee, and ant stings. Allergy shots are the only treatment known to modify disease progression, making them life-saving for severe allergy sufferers.
Researchers identified seven potential candidate genes as targets for melanoma immunotherapy, including cancer-testis genes and melanoma-related genes. The NCI is currently conducting clinical trials using this technology to treat various cancers.
Researchers developed prognostic biomarkers to determine melanoma patient benefit from new immunotherapy agents. Epigenetic regulators like microRNAs were found to inhibit metastasis and improve chemotherapy response in triple negative breast cancer.
A new two-step immunotherapy approach, combining dendritic cell vaccination and adoptive T-cell therapy, showed a 75% clinical benefit in 31 ovarian cancer patients. The treatment preserved tumor cells alive and used them to manufacture personalized vaccines that taught the immune system to attack the tumor.
Researchers found moderate evidence supporting the use of sublingual immunotherapy to improve asthma symptoms and decrease medication use by over 40% in treated patients. The treatment also showed promise for reducing symptoms of allergic rhinitis and conjunctivitis, with no reported episodes of anaphylaxis or death.
A new study published in The Journal of Allergy & Clinical Immunology shows that immunotherapy using peanut protein drops can desensitize patients to peanuts by up to 10 times. After 44 weeks, 70% of participants increased their safe consumption level from 3.5mg to 496mg.
A new study funded by NIH suggests that sublingual immunotherapy (SLIT) can reduce the allergic response to peanut in adolescents and adults, increasing their tolerance to peanut. The treatment approach involves placing a small amount of allergen under the tongue under medical supervision.
Combining chemotherapy and immunotherapy results in enhanced anti-tumor effect, contrary to previous assumption that they would cancel each other out. The mechanism involves the upregulation of mannose-6-phosphate receptor on tumor cells, which is triggered by autophagy.
Researchers found that administering immunotherapy for three years can achieve long-term control of allergic asthma and reduce symptoms. After three years, 50 percent of children with dust mite-induced asthma experienced remission, needing reduced or no controller medications.
A multi-center study of 55 children found that oral immunotherapy reduced allergic reactions, allowing most to consume eggs without symptoms. The therapy showed promise in desensitizing children to egg allergies, representing a promising therapeutic intervention.
A study published in Archives of Neurology found that early-initiated immunotherapy is associated with improved seizure outcomes among patients with autoimmune epilepsy. In a cohort of 32 patients, 81% reported improvement after immunotherapy and 44% were seizure-free within 12 weeks.
A study published in NEJM describes a rare case of the abscopal effect in a melanoma patient, where combining targeted radiation therapy with immunotherapy led to a strong immune response and favorable clinical outcome. The patient's pre-existing immunity to NY-ESO-1 antigen played a crucial role in the enhanced tumor regression.
A new study found that combination immunotherapy nearly doubles five-year survival among patients with advanced Sezary Syndrome, a rare leukemic form of cutaneous T-cell lymphoma. The therapy approach comprised extracorporeal photopheresis and systemic immunostimulatory agents.
A new Cochrane Systematic Review finds sublingual immunotherapy significantly reduces symptoms of allergic rhinitis and medication requirements. The treatment has very few serious adverse effects and is effective in children, offering a convenient alternative to injection immunotherapy.
Researchers propose new clinical trial endpoints for immunotherapies, accounting for delayed responses and novel patterns of anti-tumor activity. The immune-related response criteria (irRC) offer a revised approach to measuring treatment success, considering factors such as lymphocyte infiltration and tumor burden.
Researchers have identified three protein fragments in gluten that trigger an immune response in people with coeliac disease, leading to small intestine damage. This discovery could pave the way for a new generation of diagnostic tools, treatments, and prevention strategies.
A preclinical study suggests combining targeted therapy against the BRAF/MAPK pathway with immunotherapy may improve durability of responses in treating melanoma. Researchers found that inhibiting the MAPK pathway resulted in increased antigen expression, leading to improved recognition by T-cells.
Researchers at Yale University found that carbon nanotubes cause T cell antigens to cluster in high concentrations, stimulating the body's natural immune response. This breakthrough could improve current adoptive immunotherapy for cancer treatment by increasing T cell proliferation.
The study demonstrates a potential new treatment paradigm in oncology with improved overall survival rates for metastatic castration-resistant prostate cancer patients. The treatment, Sipuleucel-T, was shown to have well-balanced prognostic factors and mild adverse events.
A new study suggests that stimulating human lung cancer cells with TLR7 or TLR8 agonists can lead to increased tumor cell survival and resistance to chemotherapy. This approach is being investigated as an adjuvant for anticancer immunotherapies, but caution should be exercised due to these potential risks.
Researchers at Johns Hopkins Children's Center report encouraging results in children with egg allergies who consume increasingly higher doses of egg protein. The study found that more than half of the children could tolerate 5 grams of eggs without an allergic reaction, experiencing mild to moderate symptoms.
The Phase 3 IMPACT trial found that sipuleucel-T significantly prolonged overall survival by 4.1 months and improved three-year survival by 38 percent compared to placebo. This innovative immunotherapy reduced the risk of death by 22.5 percent.
Researchers found that gradually increasing doses of milk protein over time can help children with severe and persistent milk allergy tolerate the allergen, reducing symptoms and building tolerance. The study suggests oral immunotherapy may be a promising treatment option for food allergies.
Researchers at the University of Montreal and Argos Therapeutics have developed a novel method to create personalized immunotherapy treatments for HIV. The treatment uses dendritic cell-based therapies that stimulate the expansion of HIV-specific T cells, which attack and kill infected cells.
Researchers found that standard flu vaccine boosted immune function in patients with recurrent or metastatic Ewing's sarcoma and alveolar rhabdomyosarcoma, leading to higher five-year overall survival rates. The study suggests immunotherapy could be beneficial for high-risk pediatric sarcomas.
Researchers have developed a new immunotherapy technique called OPAL therapy that stimulates immunity and controls virus levels in HIV-infected individuals. The treatment involves reinfusing fresh blood cells with overlapping peptides, showing promise in preventing AIDS progression.
A six-week experimental allergy treatment has relieved hay fever symptoms for at least two years in a clinical trial. The novel DNA-based drug AIC blocks the seasonal rise in ragweed-specific IgE and reduces IL-4, hinting at successful immune system reprogramming.
Researchers found that children who received venom allergy shots had significantly fewer life-threatening reactions when restung, even years later. Dr. Rebecca Gruchalla recommends the shots for kids with severe allergic reactions to insect stings, which are responsible for at least 40 fatal stings per year.
A study found that children who received venom immunotherapy for moderate to severe allergic reactions had a lower risk of future reactions, including those with no prior treatment. The therapy was shown to last for up to three and a half years, making it an effective long-term solution for managing bee sting allergies.
A randomized clinical trial showed that adjuvant chemotherapy and immunotherapy for colon cancer patients offer no disease-free or overall survival benefits after 10 years. The improvements in 5-year survival rates observed in the past have disappeared over time, suggesting that newer chemotherapy regimens may be more effective.
IVIg is the preferred treatment for Guillain-Barré Syndrome due to its ease of use and lower complication rate compared to plasma exchange. Early treatment within two weeks of symptom onset improves chances for a better outcome.
Researchers investigating a potential new treatment for type 1 diabetes found severe allergic reactions in mice, raising concerns about its safety. The study's findings contrast with earlier mouse studies suggesting the treatment could reduce incidence of diabetes, and highlight the need for cautious evaluation of immunotherapy research.
Researchers at the University of Melbourne have developed a potential allergy vaccine using a modified rye grass protein that reduces allergenic response while boosting immune system. The vaccine, delivered in its pure form, may significantly reduce risk of anaphylactic shock and increase immunotherapy efficacy.
Researchers found that rush immunotherapy targeting a single allergen makes distinct changes in T cells and prevents allergic reactions. The study showed that T cells produce more interferon gamma, an element that lowers allergic responses, and shut off production of pro-allergic cytokines.